Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
7.54M
-
Shares change
-
-979K
-
Total reported value, excl. options
-
$43.3M
-
Value change
-
-$6.49M
-
Number of buys
-
15
-
Number of sells
-
-33
-
Price
-
$5.74
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2022
56 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q2 2022.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.54M shares
of 22M outstanding shares and own 34.2% of the company stock.
Largest 10 shareholders include COWEN AND COMPANY, LLC (1.36M shares), Stonepine Capital Management, LLC (1.26M shares), RTW INVESTMENTS, LP (1.03M shares), WASATCH ADVISORS INC (1.01M shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (496K shares), VANGUARD GROUP INC (491K shares), PLATINUM INVESTMENT MANAGEMENT LTD (400K shares), PERKINS CAPITAL MANAGEMENT INC (237K shares), Nantahala Capital Management, LLC (156K shares), and UBS Group AG (132K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.